Detalles de la búsqueda
1.
Activation of the PI3K/AKT/mTOR pathway in diffuse large B cell lymphoma: clinical significance and inhibitory effect of rituximab.
Ann Hematol
; 92(10): 1351-8, 2013 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-23636313
2.
HSP70-Hrd1 axis precludes the oncorepressor potential of N-terminal misfolded Blimp-1s in lymphoma cells.
Nat Commun
; 8(1): 363, 2017 08 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-28842558
3.
Combination of rituximab and mammalian target of rapamycin inhibitor everolimus (RAD001) in diffuse large B-cell lymphoma.
Leuk Lymphoma
; 55(5): 1151-7, 2014 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-23841505
4.
[Research progress on B lymphocyte-induced maturation protein 1 and its relationship with the development of lymphoma].
Zhongguo Shi Yan Xue Ye Xue Za Zhi
; 21(6): 1623-6, 2013 Dec.
Artículo
en Zh
| MEDLINE | ID: mdl-24370060
Resultados
1 -
4
de 4
1
Próxima >
>>